Illustrative image – not actual.Ahmedabad based Cadila Pharmaceuticals Ltd (CPL) has formed a JV with US based Novavax. The newly formed JV is named as CPL Biologicals.
Under the tie-up, a new vaccine manufacturing facility will be set up with an initial investment of Rs 100 crore in Dholka, Gujarat. The Dholka facility will be developed on a part of the 160 acre owned by CPL and is likely to be commissioned by 2011.
The JV is expected to develop and manufacture vaccines such as influenza vaccine and other novel vaccines based on the VLP (Virus Like Particles) technology, biological therapeutics and diagnostics in India using technology contributed from Novavax and CPL. As per this partnership, Novavax will also transfer its technology.
